← Leaderboards
Unsong Oh
Virginia Commonwealth University
$579,438
Attributed
$579,438
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.9K · FY2017–25$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$579,438 · 2
By mechanism
R21$426,938 · 1
R03$152,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- John T. Povlishock$16,843,993
- Jeremy Allen Meier$124,380
- Thomas E Krahe$978,313
- Henry J Rozycki$223,263
- Cynthia Nau Cornelissen$16,417,118
Others in their field
Other Emerging Leaders on “Knockout Mice”
- Jacqueline K White · Jackson Laboratory$12,630,880
- Sonia Minikel Vallabh · Broad Institute, Inc.$7,047,559
- William Raymond Lagor · Baylor College Of Medicine$6,613,818
- George R Uhl · National Institute On Drug Abuse$6,473,982
- Prashant Mishra · Ut Southwestern Medical Center$5,429,512
- James Amos-Landgraf · University Of Missouri-Columbia$5,263,805
Research focus
Knockout MiceNovel TherapeuticsAnimalsAnimal ModelMediatingImmune ResponseAutoantigensAdoptive TransferGlial Fibrillary Acidic ProteinDoseAntigen TestAquaporin 4AblationAutoimmuneEnterobacteria Phage P1 Cre RecombinaseAdeno-Associated Viral VectorConfounding Factors (Epidemiology)Barrier To TestingAntigensBlindnessAntigen TargetingDisablingAutoimmunityAnimal Model Development
Grant awards (4)
An animal model of anti-AQP4 autoimmunity$194,063
R21 · FY2025 · AI · contact PI
An animal model of anti-AQP4 autoimmunity$232,875
R21 · FY2024 · AI · contact PI
The contribution of cyclophilin A to immune-mediated inflammatory disorders of the central nervous system$76,250
R03 · FY2018 · NS · contact PI
The contribution of cyclophilin A to immune-mediated inflammatory disorders of the central nervous system$76,250
R03 · FY2017 · NS · contact PI